Oral polyunsaturated fatty acid supplementation as adjuvant therapy for asthmatic children Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012
Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006
Intake of n -3 polyunsaturated fatty acids in childhood, FADS genotype and incident asthma Source: Eur Respir J, 58 (3) 2003633; 10.1183/13993003.03633-2020 Year: 2021
Intake of antioxidants and n-3 and n-6 PUFA in relation to asthma and eczema in a cohort of pregnant women Source: Eur Respir J 2002; 20: Suppl. 38, 428s Year: 2002
Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007
Effectiveness of omega-3 polyunsaturated fatty acids in combination with acetylsalicylic acid in patients with COPD, complicated by cor pulmonale and the syndrome of blood hypercoagulation Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004
The effect of conjugated linoleic acid supplementation on the nutritional status of COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016
The n-3 long chain polyunsaturated fatty acids (n-3LCPUFA) are inversely linked to asthma and persistent symptoms of allergy in children born to mothers with allergy Source: Eur Respir J 2006; 28: Suppl. 50, 251s Year: 2006
Effects of long-term supplementation of branched-chain amino acids on muscle metabolism in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 638s Year: 2006
Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon? Source: Eur Respir J, 58 (3) 2101386; 10.1183/13993003.01386-2021 Year: 2021
Effect of suplementary dietary antioxidants in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006
Prenatal polyunsaturated fatty acid exposure is associated with childhood atopy and wheeze Source: Annual Congress 2010 - Paediatric epidemiology Year: 2010
Late Breaking Abstract: Prenatal n-3, n-6, and trans fatty acids and the risk of eosinophilia and allergic sensitization in children at age 3 years Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring Year: 2010
The effects of conjugated linoleic acid supplementation on the serum levels of Interleukin-6 and Sirtuin-1 in COPD patients Source: International Congress 2019 – Basic research of airway diseases Year: 2019
Association between Ω3 and Ω6 fatty acid dietary intakes and serum inflammatory markers in Spanish COPD patients Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010
Supplementation with omega-3 fatty acids and atopy symptoms in infants: a randomized controlled trial Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008
An application of omega-3 polyunsaturated fatty acids in treatment of COPD patients with pulmonary hypertension and chronic cor pulmonale Source: Eur Respir J 2001; 18: Suppl. 33, 251s Year: 2001
The role of partially hydrolysed formulae, probiotics and omega-3 fatty acids in cow‘s milk allergy in children Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009
Effect of omega-3 fatty acid (O3FA) from fish oils on mannitol-induced airway hyperresponsiveness (AHR) & sputum eosinophils in patients with asthma Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009
Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids? Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001